Literature DB >> 29101664

High-Risk Percutaneous Coronary Intervention in Public Reporting States: the Evidence, Exclusion of Critically Ill Patients, and Implications.

Rishi K Wadhera1,2, Jordan D Anderson2, Robert W Yeh3.   

Abstract

PURPOSE OF REVIEW: Public reporting of outcomes for percutaneous coronary intervention (PCI) is used in some states to drive improvements in care delivery and performance. However, a growing body of evidence suggests unintended consequences, particularly provider aversion to performing PCI in high-risk patients. RECENT
FINDINGS: There is mixed evidence regarding the impact of PCI public reporting on patient outcomes. In addition, providers in public reporting states likely have a higher threshold or potentially avoid performing PCI on high-risk patients, such as those with cardiogenic shock. The exclusion of patients with refractory cardiogenic shock from public reports in New York state has reduced provider risk aversion. Though this represents a step in the right direction, other strategies are needed to diminish continued provider risk aversion and strengthen PCI care quality. Public reporting initiatives for PCI are beginning to proliferate nationally. However, the challenge of fostering the positive of aspects of reporting, which incentivize improved care quality and procedural performance, while ensuring that high-risk patients continue to receive appropriate care remains. It is imperative that policymakers and cardiologists continue to develop innovative solutions that address risk aversive provider behaviors towards high-risk patients.

Entities:  

Keywords:  Acute myocardial infarction; Cardiogenic shock; Percutaneous coronary intervention; Public reporting

Mesh:

Year:  2017        PMID: 29101664      PMCID: PMC5705023          DOI: 10.1007/s11897-017-0369-1

Source DB:  PubMed          Journal:  Curr Heart Fail Rep        ISSN: 1546-9530


  19 in total

1.  Surgical ineligibility and mortality among patients with unprotected left main or multivessel coronary artery disease undergoing percutaneous coronary intervention.

Authors:  Stephen W Waldo; Eric A Secemsky; Cashel O'Brien; Kevin F Kennedy; Eugene Pomerantsev; Thoralf M Sundt; Edward J McNulty; Benjamin M Scirica; Robert W Yeh
Journal:  Circulation       Date:  2014-11-12       Impact factor: 29.690

2.  Doing what's right for the resuscitated.

Authors:  Paul W McMullan; Christopher J White
Journal:  Catheter Cardiovasc Interv       Date:  2010-07-01       Impact factor: 2.692

Review 3.  Public Reporting of Mortality After PCI in Cardiac Arrest and Cardiogenic Shock: An Opinion From the Interventional Council and the Board of Governors of the American College of Cardiology.

Authors:  Tanveer Rab; Hadley Wilson
Journal:  JACC Cardiovasc Interv       Date:  2016-03-14       Impact factor: 11.195

4.  State mandated public reporting and outcomes of percutaneous coronary intervention in the United States.

Authors:  Matthew A Cavender; Karen E Joynt; Craig S Parzynski; Frederick S Resnic; John S Rumsfeld; Mauro Moscucci; Frederick A Masoudi; Jeptha P Curtis; Eric D Peterson; Hitinder S Gurm
Journal:  Am J Cardiol       Date:  2015-03-12       Impact factor: 2.778

5.  Quality of Care at Hospitals Identified as Outliers in Publicly Reported Mortality Statistics for Percutaneous Coronary Intervention.

Authors:  Stephen W Waldo; James M McCabe; Kevin F Kennedy; Corwin M Zigler; Duane S Pinto; Robert W Yeh
Journal:  Circulation       Date:  2017-03-01       Impact factor: 29.690

6.  Management of Patients With Cardiac Arrest Complicating Myocardial Infarction in New York Before and After Public Reporting Policy Changes.

Authors:  Jordan B Strom; James M McCabe; Stephen W Waldo; Duane S Pinto; Kevin F Kennedy; Dmitriy N Feldman; Robert W Yeh
Journal:  Circ Cardiovasc Interv       Date:  2017-05       Impact factor: 6.546

7.  Public reporting and case selection for percutaneous coronary interventions: an analysis from two large multicenter percutaneous coronary intervention databases.

Authors:  Mauro Moscucci; Kim A Eagle; David Share; Dean Smith; Anthony C De Franco; Michael O'Donnell; Eva Kline-Rogers; Sandeep M Jani; David L Brown
Journal:  J Am Coll Cardiol       Date:  2005-06-07       Impact factor: 24.094

Review 8.  Implications of Public Reporting of Risk-Adjusted Mortality Following Percutaneous Coronary Intervention: Misperceptions and Potential Consequences for High-Risk Patients Including Nonsurgical Patients.

Authors:  Anuj Gupta; Robert W Yeh; Jacqueline E Tamis-Holland; Shalin H Patel; Robert A Guyton; Lloyd W Klein; Tanveer Rab; Ajay J Kirtane
Journal:  JACC Cardiovasc Interv       Date:  2016-10-24       Impact factor: 11.195

9.  The influence of public reporting of outcome data on medical decision making by physicians.

Authors:  Craig R Narins; Ann M Dozier; Frederick S Ling; Wojciech Zareba
Journal:  Arch Intern Med       Date:  2005-01-10

10.  Treatment and Outcomes of Acute Myocardial Infarction Complicated by Shock After Public Reporting Policy Changes in New York.

Authors:  James M McCabe; Stephen W Waldo; Kevin F Kennedy; Robert W Yeh
Journal:  JAMA Cardiol       Date:  2016-09-01       Impact factor: 14.676

View more
  4 in total

1.  Public Reporting of Percutaneous Coronary Intervention Outcomes: Institutional Costs and Physician Burden.

Authors:  Rishi K Wadhera; Colin W O'Brien; Karen E Joynt Maddox; Kalon K L Ho; Duane S Pinto; Frederic S Resnic; Pinak B Shah; Robert W Yeh
Journal:  J Am Coll Cardiol       Date:  2019-03-15       Impact factor: 24.094

Review 2.  Public Reporting of Percutaneous Coronary Intervention Outcomes: Moving Beyond the Status Quo.

Authors:  Rishi K Wadhera; Karen E Joynt Maddox; Robert W Yeh; Deepak L Bhatt
Journal:  JAMA Cardiol       Date:  2018-07-01       Impact factor: 14.676

3.  Inadequate Surrogates for Imperfect Quality Measures.

Authors:  Rishi K Wadhera; Robert W Yeh
Journal:  Circ Cardiovasc Interv       Date:  2018-09       Impact factor: 6.546

Review 4.  Impact of public release of performance data on the behaviour of healthcare consumers and providers.

Authors:  David Metcalfe; Arturo J Rios Diaz; Olubode A Olufajo; M Sofia Massa; Nicole Abm Ketelaar; Signe A Flottorp; Daniel C Perry
Journal:  Cochrane Database Syst Rev       Date:  2018-09-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.